US Food and Drug Administration – Charm

China’s SciNeuro, Novartis sign US$1.7 billion licensing deal to develop Alzheimer’s drugs

17 hours ago02 mins

A partnership between China’s SciNeuro Pharmaceuticals and Swiss pharmaceutical giant Novartis on Monday has revived hopes for treating Alzheimer’s disease. The deal, worth nearly US$1.7 billion, grants Novartis exclusive worldwide rights to develop and commercialise SciNeuro’s antibody candidates to develop drugs for the progressive brain disease. SciNeuro’s novel amyloid beta targeted antibody programme leverages proprietary…

FDA intends to put its most serious warning on Covid vaccines, sources say

Cs news1 month ago018 mins

The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans. A boxed warning, which appears at the top of prescribing information for medicines, is the agency’s most serious, designed to warn about risks such as death or life-threatening or disabling…

Opinion | Where US jealously guards tech, China offers a collaborative ecosystem

Cs news6 months ago03 mins

Windsurf was a rising artificial intelligence (AI) start-up – until it wasn’t. Days after OpenAI’s US$3 billion acquisition deal collapsed, Windsurf’s founders and top researchers joined Google DeepMind under a non-exclusive licensing agreement. What remained was sold to another company. Windsurf, as an independent innovator, ceased to exist. This is how many AI start-ups today…